Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiopulmonary Capacity and TSH Levels in the Elderly and Effect of Methimazole
NCT01849861Phase 4Unknown
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Sep 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methimazole, sponsored by Federal University of Rio de Janeiro. Primary endpoint: Cardiopulmonary capacity at 6 months. Status: unknown.
02
Drugs
methimazole
Beyond the preview
Go deeper on NCT01849861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849861.